Lindgardt Zhenya, the Chief Executive Officer of Sera Prognostics , Inc. (NASDAQ:SERA), recently sold 14,075 shares of the company's Class A common stock. The shares were sold at a weighted average price of $4.

The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.

Sera Prognostics (SERA) announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of

SALT LAKE CITY—Aerts Austin, the Chief Financial Officer of Sera Prognostics , Inc. (NASDAQ:SERA), a company with a market capitalization of $137.45 million, executed a stock sale valued at approximately $27,

Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,